Fuse Medical (Fuse Medical) Cash-to-Debt : 0.11 (As of Jun. 2023)

View and export this data going back to . Start your Free Trial

What is Fuse Medical Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Fuse Medical's cash to debt ratio for the quarter that ended in Jun. 2023 was 0.11.

If Cash to Debt ratio is less than 1, the company cannot pay off its debt using the cash in hand. Here we can see, Fuse Medical couldn't pay off its debt using the cash in hand for the quarter that ended in Jun. 2023.

The historical rank and industry rank for Fuse Medical's Cash-to-Debt or its related term are showing as below:

FZMD' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.03 Med: 0.54 Max: 4
Current: 0.11

During the past 13 years, Fuse Medical's highest Cash to Debt Ratio was 4.00. The lowest was 0.03. And the median was 0.54.

FZMD's Cash-to-Debt is ranked worse than
91.37% of 846 companies
in the Medical Devices & Instruments industry
Industry Median: 1.955 vs FZMD: 0.11

Fuse Medical Cash-to-Debt Historical Data

The historical data trend for Fuse Medical's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Fuse Medical Cash-to-Debt Chart

Fuse Medical Annual Data

Trend

Aug13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Cash-to-Debt

Get a 7-Day Free Trial

0.52

0.58

0.67

0.20

0.06

Fuse Medical Quarterly Data
	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23
Cash-to-Debt	Get a 7-Day Free Trial															0.23	0.21	0.06	0.10	0.11

Competitive Comparison of Fuse Medical's Cash-to-Debt

For the Medical Devices subindustry, Fuse Medical's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Fuse Medical's Cash-to-Debt Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Fuse Medical's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Fuse Medical's Cash-to-Debt falls into.

Fuse Medical Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Fuse Medical's Cash to Debt Ratio for the fiscal year that ended in Dec. 2022 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	0.148	/	(2.147	+	0.2)
	=	0.06

Fuse Medical's Cash to Debt Ratio for the quarter that ended in Jun. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	0.253	/	(2.221	+	0)
	=	0.11

Fuse Medical (OTCPK:FZMD) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

Fuse Medical Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of Fuse Medical's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Fuse Medical (Fuse Medical) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Fuse Medical Inc (OTCPK:FZMD) » Definitions » Cash-to-Debt

Comparable Companies

Traded in Other Exchanges

N/A

Address

1565 N. Central Expressway, Suite 220, Richardson, TX, USA, 75080

Website

https://www.fusemedical.com

Fuse Medical Inc is a manufacturer and distributor of medical devices. The company provides a comprehensive portfolio of products in the orthopedic total joints, sports medicine, trauma, foot and ankle space, as well as degenerative and deformity spine, orthobiologics, and regenerative medicine.

Executives

Lawrence Scott Yellin	director, officer: Chief Financial Officer	5081 PINEVIEW CIRCLE, DELRAY BEACH FL 33445
Christopher C Reeg	director, 10 percent owner, officer: Chief Executive Officer	3024 WESTMINSTER AVE, DALLAS TX 75205
Reeg Medical Industries, Inc.	10 percent owner	3024 WESTMINSTER AVE., DALLAS TX 75205
Mark W Brooks	10 percent owner	1565 NORTH CENTRAL EXPRESSWAY, SUITE 200, RICHARDSON TX 75080
Bosita Renato V. Jr.	director	TEXAS BACK INSTITUTE, 6020 WEST PARKER ROAD #200, PLANO TX 75025
Kalra Ricky Raj S.	director	2513 SUNTREE LANE, PLANO TX 75025
Nc 143 Family Holdings, Lp	10 percent owner	1565 NORTH CENTRAL EXPRESSWAY, SUITE 200, RICHARDSON TX 75080
Medtech Family Trust	10 percent owner	1565 NORTH CENTRAL EXPRESSWAY, SUITE 200, RICHARDSON TX 75080
Mclaughlin William E Iii	director	1565 NORTH CENTRAL EXPRESSWAY, 2ND FLOOR, RICHARDSON TX 75080
Nc 143 Family Holdings Gp Llc	10 percent owner	1565 NORTH CENTRAL EXPRESSWAY, SUITE 200, RICHARDSON TX 75080
Chris Pratt	director, 10 percent owner, officer: Chief Medical Officer	4770 BRYANT IRVIN COURT, SUITE 300, FORT WORTH TX 76107
Randall Dei	director, officer: Medical Director of Podiatry	4770 BRYANT IRVIN COURT, SUITE 300, FORT WORTH TX 76107
Rusty Shelton	director, 10 percent owner, officer: Chief Development Officer	4770 BRYANT IRVIN COURT, SUITE 300, FORT WORTH TX 76107
David Hexter	director, officer: Interim CFO	4770 BRYANT IRVIN COURT, SUITE 300, FORT WORTH TX 76107
D Alan Meeker	director, 10 percent owner, officer: Chief Executive Officer	4770 BRYANT IRVIN COURT, SUITE 400, FORT WORTH TX 76107

Fuse Medical (Fuse Medical) Headlines

From GuruFocus

Fuse Medical, Inc. Announces Second Quarter 2023 Financial Results

By Marketwired • 08-15-2023